# PHAGE Study: Bacteriophages as Novel Prebiotics

> **NCT03269617** · NA · COMPLETED · sponsor: **Colorado State University** · enrollment: 43 (actual)

## Conditions studied

- Gastrointestinal Disorder, Functional

## Interventions

- **DIETARY_SUPPLEMENT:** Bacteriophage mixture
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT03269617
- **Lead sponsor:** Colorado State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2017-05-30
- **Final completion:** 2017-05-30
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2019-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03269617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03269617, "PHAGE Study: Bacteriophages as Novel Prebiotics". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03269617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*